Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LASE Innovation
Waltham, Massachusetts, United Stateslaseinnovation.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
LASE Innovation has developed a proprietary single-cell barcoding platform using laser particles that enable massively multiplexed identification and tracking of individual cells across multiple omics platforms. Their LP Cell Barcoding™ allows researchers to connect data from flow cytometry, imaging, sequencing, and in vivo studies at unprecedented scale. The technology is in late-stage development with applications demonstrated in high-dimensional single-cell analysis and drug screening
- Modalities
- DeviceNanoparticleOptical probe technology
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on LASE Innovation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LASE Innovation.